###begin article-title 0
###xml 44 59 44 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 44 59 <span type="species:ncbi:632">Yersinia pestis</span>
Caspase-12 and the Inflammatory Response to Yersinia pestis
###end article-title 0
###begin p 1
Conceived and designed the experiments: BF RWS JWMVdM AVdV MGN. Performed the experiments: BF MBBM MCdV JH BM AD OKD MD DJdJ. Analyzed the data: BF MBBM MGN. Contributed reagents/materials/analysis tools: MCdV JH BM AD OKD MD DJdJ LABJ RAT FAGR RWS AVdV MGN. Wrote the paper: BF MBBM MGN.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Caspase-12 functions as an antiinflammatory enzyme inhibiting caspase-1 and the NOD2/RIP2 pathways. Due to increased susceptibility to sepsis in individuals with functional caspase-12, an early-stop mutation leading to the loss of caspase-12 has replaced the ancient genotype in Eurasia and a significant proportion of individuals from African populations. In African-Americans, it has been shown that caspase-12 inhibits the pro-inflammatory cytokine production.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 426 441 426 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 467 475 467 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 572 580 572 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 655 663 655 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 426 441 <span type="species:ncbi:632">Yersinia pestis</span>
We assessed whether similar mechanisms are present in African individuals, and whether evolutionary pressures due to plague may have led to the present caspase-12 genotype population frequencies. No difference in cytokine induction through the caspase-1 and/or NOD2/RIP2 pathways was observed in two independent African populations, among individuals with either an intact or absent caspase-12. In addition, stimulations with Yersinia pestis and two other species of Yersinia were preformed to investigate whether caspase-12 modulates the inflammatory reaction induced by Yersinia. We found that caspase-12 did not modulate cytokine production induced by Yersinia spp.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 183 192 183 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 183 192 <span type="species:ncbi:632">Y. pestis</span>
Our experiments demonstrate for the first time the involvement of the NOD2/RIP2 pathway for recognition of Yersinia. However, caspase-12 does not modulate innate host defense against Y. pestis and alternative explanations for the geographical distribution of caspase-12 should be sought.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-FuentesPrior1">[1]</xref>
###xml 84 87 84 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Nadiri1">[3]</xref>
###xml 185 188 185 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Martinon1">[2]</xref>
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Nadiri1">[3]</xref>
###xml 463 466 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Fischer1">[4]</xref>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Kachapati1">[5]</xref>
###xml 648 651 648 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Xue1">[6]</xref>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 229 240 <span type="species:ncbi:9598">chimpanzees</span>
###xml 316 322 <span type="species:ncbi:9606">humans</span>
Caspases are cysteine proteases that are involved in apoptosis and inflammation [1]-[3]. Three human caspases involved in the inflammation pathway are known, namely caspase-1, 4, and 5 [2], [3]. In other mammals such as mice and chimpanzees, another caspase with modulatory effects on inflammation is caspase-12. In humans, a truncated non-functional form of caspase-12 due to a mutation resulting in an early stop codon has largely replaced the ancient genotype [4]. Genetic and population analysis revealed that the functional form of caspase-12 is present in 20 to 30% of the African populations, while completely absent in Europe and Asia [5], [6]. Due to this particular worldwide distribution and its involvement in inflammation, caspase-12 has been proposed as an exquisite example of an immune gene changed under evolutionary pressure.
###end p 9
###begin p 10
###xml 106 109 106 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Nakagawa1">[7]</xref>
###xml 361 364 361 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Akira1">[8]</xref>
###xml 520 523 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Medzhitov1">[9]</xref>
###xml 897 901 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Li1">[10]</xref>
Functionally, caspase-12 has been reported to be involved both in the apoptotic and inflammatory pathways [7]. Whole blood stimulation with lipopolysaccharide (LPS) showed that individuals bearing the functional caspase-12 were hypo-responsive. LPS, an outer cellular membrane structure found on Gram-negative bacteria is recognized by our innate immune system [8]. The innate immune system recognizes specific pathogen structures, such as LPS through pattern recognition receptors (PRR) like toll-like receptors (TLRs) [9]. TLR4 is the most important PRR involved in the recognition of LPS, TLR2 recognizes bacterial lipopeptides, and the NOD2 receptor recognizes peptidoglycans. PRR engagement induces production of proinflammatory cytokines such as TNF-alpha and IL-1beta. The IL-1beta activation requires cleavage by another inflammatory caspase termed IL-1beta converting enzyme or caspase-1 [10].
###end p 10
###begin p 11
###xml 179 183 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 317 321 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Scott1">[12]</xref>
###xml 576 580 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Cohen1">[13]</xref>
###xml 582 586 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Hotchkiss1">[14]</xref>
###xml 744 748 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh2">[15]</xref>
###xml 923 927 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
After LPS stimulation, individuals with a functional caspase-12 produced lower TNF-alpha and IL-1beta levels compared to individuals bearing only the truncated form of caspase-12 [11]. It has been therefore proposed that caspase-12 has anti-inflammatory effects by inhibiting both the NFkappaB and caspase-1 pathways [12]. As a consequence of the altered NFkappaB and caspase-1 pathway stimulation in individuals bearing functional caspase-12, the clearance of Gram-negative bacteria may be defective and eventually this could result in a life threatening bacterial infection [13], [14]. A small clinical study among African Americans showed that the pressure of a functional caspase-12 was accompanied by an increased susceptibility to sepsis [15]. These findings were supported by a sepsis mouse model showing that caspase-12 mice had a higher bacterial count and lower pro-inflammatory cytokine production during sepsis [11].
###end p 11
###begin p 12
###xml 21 24 21 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Xue1">[6]</xref>
###xml 26 30 26 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Wang1">[16]</xref>
###xml 519 522 519 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Xue1">[6]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 1042 1046 1042 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Wang1">[16]</xref>
###xml 479 484 <span type="species:ncbi:9606">human</span>
Evolutionary studies [6], [16] determined that the loss of functional caspase-12 in Caucasian and Asian populations was caused by recent positive selection. The loss of function of caspase-12 is due to truncation of the protein, rather then modulation of mRNA transcription. These data combined with the correlation of caspase-12 with susceptibility to sepsis, lead to the hypothesis that the loss of functional caspase-12 was due to the increasing pressure of sepsis during the human migration towards Europe and Asia [6]. After blood stimulation of individuals bearing the functional and non-functional caspase-12 with LPS it was shown that the non-functional caspase-12 protein was not transcriped [11]. This indicates that early stop codon results in a loss of function of the caspase-12. However, the assumption that the loss of function of capase-12 involved in the innate immune response are based on a single study in a small number of African Americans, but no data on the function of caspase-12 in African populations are available [16].
###end p 12
###begin p 13
###xml 385 400 385 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 385 400 <span type="species:ncbi:632">Yersinia pestis</span>
This is essential for the understanding of how the selection has driven selection of caspase-12 genotypes during human history. In the present study we assessed the impact of caspase-12 genotypes on inflammation in two African populations, and the potential effect of caspase-12 on a microorganism known to have exerted intense evolutionary pressure on European and Asian populations: Yersinia pestis, the agent of bubonic plague.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Functional and non-functional caspase-12 frequencies in Mali volunteers
###end title 15
###begin p 16
###xml 371 378 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006870-t001">Table 1</xref>
###xml 462 465 462 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Kachapati1">[5]</xref>
To evaluate the effect of non-functional and functional caspase-12 genotypes on proinflammatory cytokines, blood was initially collected from 50 healthy Mali volunteers. Thirthy-three of the volunteers were homozygous (66%) for the non-functional caspase-12 allele, 16 volunteers were heterozygous (32%), and one (2%) was homozygous for the functional caspase-12 allele (Table 1). These frequencies of the caspase-12 genotypes were in line with previous reports [5].
###end p 16
###begin title 17
Caspase-12 genotypes and allele frequency in two cohorts of Mali volunteers, one collected in 2006 and one in 2007.
###end title 17
###begin p 18
Population do not violate Hardy-Weinberg equilibrium.
###end p 18
###begin p 19
###xml 90 91 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Distribution of Caspase-12 genotypes between 2006 and 2007 populations did not differ (chi2-test).
###end p 19
###begin title 20
Pro-inflammatory cytokine production of the caspase-12 genotypes
###end title 20
###begin p 21
###xml 252 261 244 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g001">Figure 1A</xref>
###xml 444 453 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g001">figure 1B</xref>
###xml 614 622 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g001">Figure 1</xref>
###xml 721 730 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g001">Figure 1C</xref>
Stimulation of whole blood was performed with either the TLR4 ligand LPS (concentrations 1, 10 and 100 ng/ml) or Pam3Cys (10 microg/ml), a TLR2 specific ligand. Similar levels of TNF-alpha between caspase-12 genotypes were observed between the groups (Figure 1A). Surprisingly, the IL-1beta production was even increased in individuals heterozygous for the functional caspase-12 allele, for all LPS concentrations tested (Mann-Whitney, P<0.05, figure 1B). In addition, the individual homozygous for the functional caspase-12 allele showed no evidence of inhibition of the production of pro-inflammatory cytokines (Figure 1). The release of the anti-inflammatory cytokine IL-10 was independent of the caspase-12 genotype (Figure 1C).
###end p 21
###begin title 22
In-vitro cytokine measurements after whole blood LPS and Pam3Cys stimulation between the caspase-12 genotypes from the volunteers enrolled in 2006.
###end title 22
###begin p 23
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 56 63 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Stimulation was performed with 1, 10 and 100 ng/ml LPS (E. coli) and 10 microg/ml Pam3Cys. TNF (A), IL-1beta (B) and IL-10 (C) were measured by ELISA in the supernatant after 24 hour stimulation. Volunteers were grouped as homozygous bearing the nonfunctional caspase-12 genotype (S/S), heterozygous bearing the nonfunctional and functional caspase-12 (S/L), and homozygous bearing the functional caspase-12 (L/L). Numbers of volunteers included for each cytokine are S/S = 33, S/L = 16 and L/L = 1. Values represent mean + SD for each group of volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test. *P<0.05.
###end p 23
###begin title 24
Replication within second field study of previous findings
###end title 24
###begin p 25
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 346 353 346 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006870-t001">Table 1</xref>
###xml 543 550 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006870-t001">Table 1</xref>
###xml 769 777 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g002">Figure 2</xref>
###xml 1021 1029 1011 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g002">Figure 2</xref>
Because the result of our initial study clearly contradicted one earlier report of inhibition of the pro-inflammatory response by caspase-12, we initiated a second field study to assess the function of caspase-12 [11]. During this second study we collected blood from 47 Mali volunteers and determined their caspase-12 genotype (volunteers 2007, Table 1). Twenty-four individuals were homozygous (51%) for the non-functional caspase-12 allele, 22 heterozygous (47%), and one volunteer was homozygous (2%) for the functional caspase-12 allele (Table 1). No difference was found between cells isolated from individuals homozygous for the non-functional caspase-12 allele and from the heterozygous volunteers, when production of TNF-alpha, IL-1beta or IL-10 was measured (Figure 2). No differences for the production of IL-1beta were found between the groups in this second study. The cytokine production of cells isolated from the volunteer homozygous for the functional caspase-12 was comparable with the other genotypes (Figure 2 B and C).
###end p 25
###begin title 26
In-vitro cytokine measurements after whole blood LPS and Pam3Cys stimulation between the caspase-12 genotypes from the volunteers enrolled in 2007.
###end title 26
###begin p 27
Stimulation with LPS was performed with 10 ng/ml. TNF (A), IL-1beta (B) and IL-10 (C) were measured by ELISA after 24-hour stimulation. Volunteers were grouped as homozygous bearing the nonfunctional caspase-12 genotype (S/S), heterozygous bearing the nonfunctional and functional caspase-12 (S/L) and homozygous that bear the functional caspase-12 (L/L). Numbers of volunteers included for each cytokine are S/S = 24, S/L = 22 and L/L = 1. Values represent mean + SD for each group of volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test.
###end p 27
###begin title 28
Yersinia spp stimulations
###end title 28
###begin p 29
###xml 322 330 322 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 347 364 347 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. enterocolitica</italic>
###xml 366 387 366 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pseudotuberculosis</italic>
###xml 392 401 392 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 403 411 403 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g003">Figure 3</xref>
###xml 426 434 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 514 522 514 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 660 668 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g003">Figure 3</xref>
###xml 347 364 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 366 387 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 392 401 <span type="species:ncbi:632">Y. pestis</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
Stimulation with pure TLR4 (LPS) and TLR2 (Pam3Cys) ligands showed no anti-inflammatory role of the functional caspase-12. The lack of inhibition could have been caused by the specific TLR stimuli used in these experiments. Therefore, whole blood from the second volunteer cohort was also stimulated with three pathogenic Yersinia species, namely Y. enterocolitica, Y. pseudotuberculosis and Y. pestis (Figure 3). These three Yersinia spp were chosen due to their important role as human pathogens. With all three Yersinia species no different pro-inflammatory cytokine production was observed between the functional and non-functional caspase-12 individuals (Figure 3). This indicates that the caspase-1 pathway was not affected by the functional caspase-12.
###end p 29
###begin title 30
###xml 66 89 66 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia enterocolitica</italic>
###xml 91 118 91 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pseudotuberculosis</italic>
###xml 123 138 123 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 66 89 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 91 118 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
###xml 123 138 <span type="species:ncbi:632">Yersinia pestis</span>
In-vitro cytokine measurements after whole blood stimulation with Yersinia enterocolitica, Yersinia pseudotuberculosis and Yersinia pestis.
###end title 30
###begin p 31
TNF (A), IL-1beta (B) and IL-10 (C) were measured by ELISA after 24-hour stimulation. Volunteers were grouped as homozygous bearing the nonfunctional caspase-12 genotype (S/S), heterozygous bearing the functional caspase-12 and nonfunctional (S/L) and homozygous that bear the functional caspase-12 (L/L). The numbers of volunteers included for each cytokine are S/S = 24, S/L = 22 and L/L = 1. Values represent mean + SD for each group of volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test.
###end p 31
###begin title 32
NOD2/RIP2 pathway
###end title 32
###begin p 33
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-LeBlanc1">[17]</xref>
###xml 249 257 249 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 309 317 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 401 409 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g004">Figure 4</xref>
###xml 548 557 544 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g004">Figure 4A</xref>
###xml 636 644 629 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 650 659 643 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g004">Figure 4B</xref>
###xml 734 742 727 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 838 846 831 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 1098 1107 1088 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g003">Figure 3B</xref>
Beside the caspase-1 pathway it has been shown that caspase-12 inhibition of the NOD2/RIP2 pathway is important for the lower pro-inflammatory cytokine release[17]. To test if the NOD2/RIP2 pathway was involved in the innate immune response against Yersinia spp. we preformed stimulations with the same three Yersinia spp. in cells isolated from individuals homozygous for the 3020insC NOD2 mutation (Figure 4). It was observed that the individuals homozygous for the 3020insC NOD2 mutation display a tendency towards reduced TNF-alpha production (Figure 4A) and a significant lower IL1-beta production after stimulation with all three Yersinia spp (Figure 4B). This demonstrates that the NOD2 receptor does play an important role in Yersinia recognition by the innate immune system. Secondly, involvement of the NOD2/RIP2 pathway during Yersinia spp recognition also indicates that if functional caspase-12 would have inhibited the pro-inflammatory response through the NOD2/RIP2 pathway, a reduction in IL-1beta production induced by Yersinia would have been expected, and that was not the case (Figure 3B).
###end p 33
###begin title 34
###xml 59 82 59 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia enterocolitica</italic>
###xml 84 111 84 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pseudotuberculosis</italic>
###xml 116 131 116 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 59 82 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 84 111 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
###xml 116 131 <span type="species:ncbi:632">Yersinia pestis</span>
In-vitro cytokine measurements after PBMC stimulation with Yersinia enterocolitica, Yersinia pseudotuberculosis and Yersinia pestis.
###end title 34
###begin p 35
###xml 153 165 153 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia spp</italic>
Caucasian individuals bearing a normal (NOD2 wt, N = 10) or homozygous for the 3020insC NOD2 mutation (NOD2 del, N = 5) were stimulated with the various Yersinia spp. TNF (A) and IL-1beta (B) were measured by ELISA after 24-hour stimulation. Values represent mean + SD for each group of volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test. *P<0.05, **P</=0.01.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 576 584 576 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g001">Figure 1</xref>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
Caspase-12 is a member of the caspase family of cysteine proteases that has been suggested to exert inhibitory effects on proinflammatory cytokines. The only populations that retain a sizeable proportion of individuals with active caspase-12 are those in Sub-Saharan Africa. The aim of the present study was to assess the effect of caspase-12 on the cytokine response of cells isolated from volunteers of African origin, after stimulation with bacterial stimuli. These experiments revealed that functional caspase-12 had no inhibitory effect on the pro-inflammatory response (Figure 1). In a small previous study performed in cells isolated from 18 African Americans (eight homozygous for the non-functional allele, eight heterozygous, two homozygous for the functional caspase-12), Saleh et al suggested that a functional caspase-12 decreased cytokine production [11;15].
###end p 37
###begin p 38
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006870-t001">Table 1</xref>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g002">Figure 2</xref>
Because our data from the first field study clearly differed from this previous investigations we repeated our experiments in cells isolated from volunteers from a second independent African population from the same region (Table 1, Figure 2). The results from the second study support the conclusion that caspase-12 had no modulatory effect on the TLR-stimulated production of cytokines.
###end p 38
###begin p 39
###xml 186 191 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 417 421 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-LeBlanc1">[17]</xref>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
In the first cohort of volunteers, we did observed an elevated IL-1beta production in individuals with an active caspase-12. Interestingly, in a colonic inflammation mouse model Leblanc et al also found that mice with a functional caspase-12 had a higher production of pro-inflammatory cytokine on day 14, although no differences in the production of the pro-inflammatory cytokines were observed early in the process [17]. However, this effect on IL-1beta production could not be reproduced in the second field study. Therefore, the overall conclusion of these two studies must be that caspase-12 is unlikely playing a major role in the modulation of the inflammatory reaction induced by LPS or bacterial lipopeptides.
###end p 39
###begin p 40
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 636 645 636 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 792 800 792 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g003">Figure 3</xref>
###xml 802 806 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Achtman1">[18]</xref>
###xml 851 868 851 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. enterocolitica</italic>
###xml 926 947 926 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pseudotuberculosis</italic>
###xml 971 980 971 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Achtman1">[18]</xref>
###xml 1044 1053 1044 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 1066 1070 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Sing1">[19]</xref>
###xml 1207 1215 1207 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 1233 1241 1233 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g004">Figure 4</xref>
###xml 1341 1349 1341 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 636 645 <span type="species:ncbi:632">Y. pestis</span>
###xml 851 868 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 926 947 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 971 980 <span type="species:ncbi:632">Y. pestis</span>
###xml 1044 1053 <span type="species:ncbi:632">Y. pestis</span>
Our first set of experiments used specific TLR4 and TLR2 ligands to elicit inflammation. However, bacterial pathogens are much more complex structures, and an effect of caspase-12 during stimulation with intact microorganisms could still be envisaged. In support of this hypothesis, it has been reported that individuals with a functional caspase-12 are more susceptible to sepsis [11]. Therefore, we wanted to assess whether stimulation of cells with various caspase-12 genotypes with complex Gram-negative microorganisms resulted in differences in pro-inflammatory cytokines. We performed stimulations with the Gram-negative bacteria Y. pestis, the agent of bubonic plague, an infection that is well-known to have induced an important evolutionary pressure on Europe and Asian populations (Figure 3) [18]. In addition, we also stimulated cells with Y. enterocolitica, an important pathogene of the digestive tract, and with Y. pseudotuberculosis the recent ancestor of Y. pestis[18]. Previous studies have shown the role of TLR2 and TLR4 for Y. pestis recognition [19]. In our stimulation of individuals with the homozygote 3020insC NOD2 mutation we demonstrate the involvement of the NOD2 pathway during Yersinia spp recognition (Figure 4). The fact that both TLR and NOD2 pathways have been proposed to be modulated by caspase-12, makes Yersinia therefore the ideal bacterial model for the assessment of caspase-12 effects.
###end p 40
###begin p 41
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Montminy1">[20]</xref>
###xml 209 218 209 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 312 320 312 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Cornelis1">[21]</xref>
###xml 624 628 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Schotte1">[22]</xref>
###xml 732 740 725 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 871 879 864 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 110 119 <span type="species:ncbi:632">Y. pestis</span>
###xml 181 187 <span type="species:ncbi:9606">humans</span>
###xml 209 218 <span type="species:ncbi:632">Y. pestis</span>
Important in the recognition of Yersinia strains is the recognition through TLR4. Montminy et al. showed that Y. pestis actively changes its LPS structure after the transmission to humans [20]. By doing this, Y. pestis actively avoids TLR4 recognition and the innate immune response necessary for the clearance. Yersinia also manipulates the innate immune system of hosts with a mechanism known as the type III secretion system [21]. Hereby Yop proteins are secreted and interfere with the inflammation response. These proteins take control of host cells by inhibiting the caspase-1-mediated maturation and IL-1beta release [22]. This indicates that both NFkappaB and caspase-1 signaling pathways are involved in the recognition of Yersinia. However, our experiments performed in a large number of volunteers bearing a functional caspase-12 do not show any modulation of Yersinia-induced cytokines, and thus of the TLR/NOD2 pathways.
###end p 41
###begin p 42
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Levasseur1">[23]</xref>
###xml 465 473 465 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 1345 1353 1345 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006870-g001">Figure 1</xref>
###xml 1562 1567 1562 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1700 1705 1700 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1991 1995 1991 1995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-OBrien1">[26]</xref>
###xml 2124 2132 2124 2132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 975 981 <span type="species:ncbi:9606">humans</span>
###xml 1021 1027 <span type="species:ncbi:9606">humans</span>
###xml 1963 1980 <span type="species:ncbi:11103">hepatitis C virus</span>
Earlier studies on the distribution of caspase-12 genotypes have shown important differences between populations [5;6], but it is unclear how environmental pressure caused selection of certain alleles, and lead to loss of caspase-12 function in the majority of individuals [23]. Our study in two African populations does not support a role for caspase-12 in the modulation of the pro-inflammatory response after TLR challenge. Similarly, no effect of caspase-12 on Yersinia stimulation of cytokines was observed. Phylogenetic analyses show that structurally, caspase-12 is grouped with the other inflammatory caspases, but the potential mechanisms through which caspase-12 potentially modulate the inflammation are still not well understood [24;25]. Most data available to date have been obtained in mice defective in caspase-12, that showed a higher cytokine response and increased resistance in bacterial models [15;17]. These data seem to be supported by a small study in humans, suggesting high cytokine responses in humans with inactive caspase-12 [11]. Unfortunately, this study has not been independently confirmed and seem to be contradicted by our data. The cause of the differences between the study of Saleh and colleagues and the present study are unclear. In our study we have performed a dose-response curve of LPS concentrations (Figure 1), and therefore it is unlikely that differences in LPS concentrations could explain the discrepancy. We have also preformed the experiments in a larger numbers of individuals than the original study of Saleh et al, and the results were verified in a second cohort. Ethnic differences between the African American volunteers in the study of Saleh et al and the Mali population investigated in our study could account for some differences, although the theoretic basis for this is unclear. The only additional study investigating the role of caspase-12 in infections found no correlation between caspase-12 and hepatitis C virus infection [26]. It is possible that caspase-12 may interact also with other PRRs than TLR4 and NOD2. However, by using whole microorganisms as Yersinia spp., that very likely stimulates also TLR2, TLR5, TLR9 (etc), we practically exclude an influence of caspase-12 on other important PRR pathways as well.
###end p 42
###begin p 43
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
In summary, the data of the present study show no regulatory role of human caspase-12 on the inflammation induced by TLR ligands or Yersinia spp. Although a role of caspase-12 for the susceptibility to sepsis can still be envisaged (which has to be confirmed in larger studies), this is highly unlikely to be mediated through modulation of cytokine response. Alternatively, the selection found in European and Asian populations on the non-functional caspase-12 may have not been caused by sepsis at all, and other biological explanations should be sought.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Volunteers
###end title 45
###begin p 46
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Dolo1">[27]</xref>
Blood samples were collected in the Koro district of Mali, West Africa during two fieldtrips in September 2006 and April 2007. These studies are part of the investigational into interethnic differences in susceptibility to malaria, as described in detail elsewhere [27]. From these volunteers we only included the healthy individuals without any suspicion or diagnosis for malaria. Approval for the study was provided by the institutional review board of the University of Bamako (Ndegrees0527/FMPOS).
###end p 46
###begin p 47
###xml 226 234 226 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Netea1">[28]</xref>
A total of 10 Dutch Caucasian controls and 5 Dutch Caucasian volunteers homozygous for the loss-of-function 3020insC NOD2 mutation were used for the stimulation experiments investigating the role of NOD2 in the recognition of Yersinia. The characteristics of the NOD2-defective individuals are described elsewhere [28].
###end p 47
###begin title 48
Cytokine stimulation assays
###end title 48
###begin p 49
###xml 313 330 313 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia colli</italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Hirschfeld1">[29]</xref>
###xml 534 557 530 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia enterocolitica</italic>
###xml 579 606 575 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pseudotuberculosis</italic>
###xml 642 665 638 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis antiqua</italic>
###xml 777 778 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 783 791 779 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
###xml 534 557 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 579 606 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
###xml 642 657 <span type="species:ncbi:632">Yersinia pestis</span>
Venous whole blood was collected into 10 ml heparin tubes (BD, Plymouth, UK) Blood from healthy individuals was diluted to a final concentration of 1:5 in RPMI 1640 medium (containing 1% glutamine, 1% pyruvate and 1% gentamicin). Stimulation was performed with control medium, highly purified lipopolysaccharide (Escherichia colli 055:B5, sigma, extra purified according to Hirshfeld et al. [29]) at various concentrations (1, 10 and 100 ng/ml), and the lipopeptide Pam3Cys (10 microg/ml, EMC Microcollections, Erlaugen). Heat-Killed Yersinia enterocolitica (clinical isolated), Yersinia pseudotuberculosis, serotype O1 (strain YERS0068) and Yersinia pestis antiqua, biovar Antiqua (strain BD94-oo544), were used for the stimulation experiments at a final concentration of 1x104/ml. Yersinia strains were cultured in BHI-broth (Tritium, Eindhoven, The Netherlands) for 48 hours at 37degreesC. The cells were resuspended in milliQ and heat treated at 95degreesC for 30 minutes. Colony forming units (CFU) and loss of viability of the cells after heat treatment were determined by plating appropriate dilutions on blood agar (Biotrading, Mijndrecht, The Netherlands) followed by incubation at 37degreesC for 48 hours. After 24 hours of stimulation at 37degreesC, supernatants were collected and stored at -80degreesC until cytokines measurements were preformed.
###end p 49
###begin p 50
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 330 338 330 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
For the stimulations of cells isolated from the NOD2-defective individuals, peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation on Ficoll, washed three times in cold RPMI, counted and resuspended in complete culture medium. PBMCs (final concentration 2.5x106/ml) were stimulated with three Yersinia strains in 96-well round-bottom plates for 24 hours at 37degreesC. After stimulation, supernatants were collected and directly used for cytokine measurement.
###end p 50
###begin title 51
Cytokine measurements
###end title 51
###begin p 52
###xml 193 197 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Grebenchtchikov1">[30]</xref>
IL-10 and IL1-beta cytokine concentrations were measured by sandwich ELISA (Sanquin, Amsterdam, The Netherlands). TNF-alpha production was measured by a specific ELISA, as previously described [30].
###end p 52
###begin title 53
Caspase-12 genotypic determination
###end title 53
###begin p 54
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006870-Saleh1">[11]</xref>
###xml 315 320 <span type="species:ncbi:9606">human</span>
DNA for all volunteers was extracted from whole blood using the Puregene (Gentra Systems, Minneapolis, MN) isolation kit. Flanking primers of the surrounding T125C polymorphism region and methodology was adopted as described by Saleh et al[11]. Sequencing was performed at the sequence faculty at the department of human genetics Nijmegen on the 48-capillary 3730 sequencer (Applied Biosystems). Genotypes of the volunteers were analyzed and determined using the software 4Peaks by A. Griekspoor and T. Groothuis (mekentosj.com).
###end p 54
###begin title 55
Statistical analysis
###end title 55
###begin p 56
###xml 120 121 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Data were analysed in SPSS (Rel.16; SPSS, Chicago, IL). Genotypic distribution between 2006 and 2007 was assessed by chi2-test. Differences in cytokine response to the stimuli between groups were analysed by Mann-Whitney. P-values<0.05 were considered statistically significant in all analysis.
###end p 56
###begin p 57
We thank D.W. Notermans for useful comments.
###end p 57
###begin title 58
References
###end title 58
###begin article-title 59
The protein structures that shape caspase activity, specificity, activation and inhibition.
###end article-title 59
###begin article-title 60
Inflammatory caspases and inflammasomes: master switches of inflammation.
###end article-title 60
###begin article-title 61
The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis.
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human caspase 12 has acquired deletrious mutations.
###end article-title 62
###begin article-title 63
Population distribution of the functional caspase-12 allele.
###end article-title 63
###begin article-title 64
###xml 44 50 <span type="species:ncbi:9606">humans</span>
Spread of an inactive form of caspase-12 in humans is due to recent positive selection.
###end article-title 64
###begin article-title 65
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta.
###end article-title 65
###begin article-title 66
Recognition of pathogen-associated molecular patterns by TLR family.
###end article-title 66
###begin article-title 67
Innate immunity.
###end article-title 67
###begin article-title 68
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.
###end article-title 68
###begin article-title 69
###xml 55 60 <span type="species:ncbi:9606">human</span>
Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.
###end article-title 69
###begin article-title 70
The inflammatory caspases: guardians against infections and sepsis.
###end article-title 70
###begin article-title 71
The immunopathogenesis of sepsis.
###end article-title 71
###begin article-title 72
The pathophysiology and treatment of sepsis.
###end article-title 72
###begin article-title 73
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice.
###end article-title 73
###begin article-title 74
###xml 19 24 <span type="species:ncbi:9606">human</span>
Gene losses during human origins.
###end article-title 74
###begin article-title 75
Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity.
###end article-title 75
###begin article-title 76
###xml 0 15 <span type="species:ncbi:632">Yersinia pestis</span>
###xml 69 96 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis.
###end article-title 76
###begin article-title 77
###xml 55 78 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.
###end article-title 77
###begin article-title 78
###xml 21 36 <span type="species:ncbi:632">Yersinia pestis</span>
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
###end article-title 78
###begin article-title 79
The Yersinia Ysc-Yop 'type III' weaponry.
###end article-title 79
###begin article-title 80
Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta.
###end article-title 80
###begin article-title 81
Conceptual bases for quantifying the role of the environment on gene evolution: the participation of positive selection and neutral evolution.
###end article-title 81
###begin article-title 82
###xml 97 102 <span type="species:ncbi:9606">human</span>
Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire.
###end article-title 82
###begin article-title 83
###xml 72 75 <span type="species:ncbi:9606">man</span>
Alice in caspase land. A phylogenetic analysis of caspases from worm to man.
###end article-title 83
###begin article-title 84
###xml 0 3 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
HCV infection clearance with functional or non-functional caspase-12.
###end article-title 84
###begin article-title 85
Difference in susceptibility to malaria between two sympatric ethnic groups in Mali.
###end article-title 85
###begin article-title 86
NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
###end article-title 86
###begin article-title 87
###xml 92 98 <span type="species:ncbi:10090">murine</span>
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.
###end article-title 87
###begin article-title 88
###xml 59 64 <span type="species:ncbi:9606">human</span>
Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies.
###end article-title 88
###begin p 89
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 89
###begin p 90
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a Vidi Grant of The Netherlands Organization for Scientific Research (to M.G.N.) and an FP6 European network of Excellence (BioMalPar) fellowship (to M.B.B.M.). The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.
###end p 90

